ARV Intolerance in Africa

Research suggests some AIDS patients are developing drug intolerance and severe side effects

New research suggests that some AIDS patients are developing drug intolerance and severe side effects and will now have to switch to new, more expensive antiretroviral regimens.

Researchers in Zimbabwe, Uganda, Nigeria and Malawi say some patients on the first-line antiretroviral drugs nevirapine and efavirenz (EFZ) are showing signs of being intolerant to the two drugs.

Daniel Sibanda, researcher at the University of Zimbabwe states that while not many studies had been carried out on drug intolerance and side effects of antiretroviral therapy (ART), new research had found that there are toxicity concerns for some patients.

To read the article titled, “Africa: ARV Intolerance - a Growing Problem for Aids Treatment in Africa,” click here.

Source: 
All Africa

NGO Services

NGO Services

NGO Events

S M T W T F S
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31